Home
|
Inbox
|
Search
|
Speaker
Lyne Gagnon
Ph.D.
Prometic Biosciences Inc.
Session(s)
- Plasminogen Reduces Lung Fibrosis in the Bleomycin-Induced Lung Fibrosis Model [Board No. ...
Sunday, May 20 2:15 PM - 4:15 PM - Evaluation of the Effect of PBI-4050 Alone or in Combination with Pirfenidone or Nintedani...
Sunday, May 20 3:30 PM - 3:45 PM - PBI-4050, a Novel First-in-Class Agent, Improves Hypoxia/Sugen Induced Pulmonary Arterial ...
Monday, May 21 2:15 PM - 4:15 PM - PBI-4050, a Novel First-in-Class Antifibrotic Agent, Improves Pulmonary Hypertension and F...
Monday, May 21 2:15 PM - 4:15 PM - PBI-4050 Therapy Selectively Improves Pulmonary Hypertension, Lung Remodeling and Right Ve...
Monday, May 21 2:15 PM - 4:15 PM
|
Home
|
Inbox
|
Search
|